A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Fazadinium bromide
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fazadinium bromide.
2,5-Dimethoxyamphetamine
Cyclobarbital
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Cyclobarbital.
2,5-Dimethoxyamphetamine
Methylpentynol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Methylpentynol.
2,5-Dimethoxyamphetamine
Vinyl ether
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Vinyl ether.
2,5-Dimethoxyamphetamine
Niaprazine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Niaprazine.
2,5-Dimethoxyamphetamine
Mosapramine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Mosapramine.
2,5-Dimethoxyamphetamine
Fluanisone
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fluanisone.
2,5-Dimethoxyamphetamine
Hexapropymate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Hexapropymate.
2,5-Dimethoxyamphetamine
Alcuronium
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Alcuronium.
2,5-Dimethoxyamphetamine
Loprazolam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Loprazolam.
2,5-Dimethoxyamphetamine
Pridinol
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Pridinol.
2,5-Dimethoxyamphetamine
Fabomotizole
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Fabomotizole.
2,5-Dimethoxyamphetamine
Oxiracetam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Oxiracetam.
2,5-Dimethoxyamphetamine
Diethyl ether
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Diethyl ether.
2,5-Dimethoxyamphetamine
Naftidrofuryl
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Naftidrofuryl.
2,5-Dimethoxyamphetamine
Gallamine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Gallamine.
2,5-Dimethoxyamphetamine
Allobarbital
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Allobarbital.
2,5-Dimethoxyamphetamine
Emylcamate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Emylcamate.
2,5-Dimethoxyamphetamine
Thiopropazate
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Thiopropazate.
2,5-Dimethoxyamphetamine
Moperone
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Moperone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3